Transdermal N-ÄN-Ä5-Ä4-(aminoiminomethyl)phenylÜ-1-oxopentylÜ-L-alpha-aspartylÜ-L-phenylalanine or its esters and their pharmaceutically acceptable salts

Transdermal N-ÄN-Ä5-Ä4-(aminoiminomethyl)phenylÜ-1-oxopentylÜ-L-alpha-aspartylÜ-L-phenylalanine or its esters and their pharmaceutically acceptable salts

The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L-alpha-aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibito...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GRIFFIN MARTIN JOHN, FEIGEN LARRY P
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L-alpha-aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors.